Ask Rose

Should I build or buy an ASC?

The short answer

Buy an existing ASC when a center in your market already matches your case mix and holds a strong payer position, because you gain case volume and standing on day one; build when no target fits your specialties or geography. In Rose, you see both paths scored side by side.

How Rose answers it

Ask in plain words

Type "Should I build or buy in this market?" and Rose returns a charted read on where volume, competition, and payer standing favor each path.

Both paths, side by side

Rose charts a build vs buy comparison for your target market, so you can weigh time to first case, competitive position, and case mix fit at a glance.

Ends in a call

Every answer closes with a clear recommendation: buy a specific fit, pursue surgery center development, or wait, with the reasoning laid out.

Build or Buy: Which Decision Actually Fits Your Situation

Buy if you need cash flow inside a year and there are viable centers for sale in your market. Build if you want a purpose-designed facility, control of the case mix, and you can carry 12 to 24 months of pre-revenue timeline. The right answer follows your capital, your surgeon commitments, and your appetite for entitlement risk. Buying gets you an existing payer contract stack, licensure, accreditation, and a running staff, but you inherit whatever is broken. Building gives you clean specs and no legacy debt, but every approval and payer contract starts at zero. Most operators choose based on how fast they need volume live and how much construction risk they can absorb.

What Building a New ASC Really Costs and How Long It Takes

Budget for a multi-year runway and single-digit millions per industry estimates, before you count land, equipment, and working capital to reach breakeven. Timelines commonly run 12 to 24 months from decision to first case, and often longer where Certificate of Need review applies. The costs that surprise first-time developers are not the OR shells. They are permitting delays, equipment lead times, payer contracting that cannot start until you hold a license, and the months of payroll you carry before volume ramps. Build only when you have committed surgeon volume in writing and a financing partner who understands healthcare construction draws. Ask Rose to profile the surgeons and case mix in a candidate market before you commit a dollar to design.

What You Actually Inherit When You Buy an Existing Center

You buy the good and the bad together: live payer contracts, accreditation, a trained staff, and a book of cases, alongside deferred maintenance, aging equipment, unfavorable rates, and whatever culture the prior owner built. The value of an acquisition lives in diligence, not the pitch deck. Pull the payer contract schedule, the case mix by CPT, out-of-network exposure, staff turnover, equipment age, and the real reason the seller is selling. A center running strong volume at weak rates is a fixable problem. A center with a thin surgeon panel and one anchor physician near retirement is a different risk entirely. Ask Rose to map the referring and operating surgeons tied to a target center so you know how durable the volume is before you sign an LOI.

Follow the Surgeon Volume, Not the Real Estate

An ASC is a volume business, so the single most important variable in build-versus-buy is committed surgeon cases, not the building. Both paths fail the same way: a beautiful center with empty ORs. Before you choose, quantify who will bring cases, what specialties, what payer mix those cases carry, and how concentrated the volume is among a handful of physicians. Concentration is the quiet killer. If two surgeons drive most of your block time, one departure resets your model. Building lets you design around a syndicated group you have already recruited. Buying lets you test whether existing volume stays after a change of control. Ask Rose to profile surgeon panels, case mix, and referral patterns in your target market so the volume assumption is grounded, not hoped for.

The Money: Financing, Syndication, and Breakeven Math

Both paths usually blend physician equity, a capital or operating partner, and debt, but the cash-flow shape differs sharply. Buying can be cash-flow positive from month one; building carries a long pre-revenue burn you must fund through breakeven. Decide early whether you syndicate ownership to your surgeons, because physician equity aligns volume with the center and changes the financing conversation. Model breakeven honestly against case ramp, payer mix, and fixed staffing, then stress it: what happens if volume arrives two quarters late or an anchor surgeon leaves. Management-company partners bring contracting leverage and operating systems in exchange for equity and fees, which can be worth it for a first center. Ask Rose to benchmark the payer landscape in a market before you finalize the pro forma.

How to De-Risk Either Path Before You Commit

Treat build-versus-buy as two diligence tracks and run the numbers before the emotion. For a build, confirm zoning, Certificate of Need exposure, construction financing, equipment lead times, and signed surgeon intent. For a buy, confirm payer contracts, case mix, equipment condition, staff retention, and the seller's true motivation. The deals that go wrong skipped the boring parts. Walk the physical plant, read every payer contract, and interview the staff you plan to keep. Model a downside case where volume lands slow and rates come in soft, and make sure the center survives it. Ask Rose to pull surgeon panels, referral relationships, and the competitive facility landscape for any market or target you are evaluating, so your decision rests on the operating reality rather than a broker's summary.

FAQ

Frequently asked questions

Is it cheaper to build or buy an ASC?

Buying usually costs less upfront in time and carries no construction risk, and it can be cash-flow positive quickly because contracts and licensure already exist. Building can cost single-digit millions per industry estimates plus a long pre-revenue burn. But a cheap acquisition with weak payer rates or thin surgeon volume often costs more over time than a well-designed build. Price the operating reality, not just the entry check.

How long does it take to open a new ASC?

Industry timelines commonly run 12 to 24 months from decision to first case, and longer in states where Certificate of Need review applies. The delays that stretch schedules are permitting, equipment lead times, accreditation, and payer contracting that cannot begin until you hold a license. Buying an existing center bypasses most of that, which is the core speed argument for acquiring rather than building.

What is the biggest risk when buying an existing surgery center?

Inheriting problems you did not price: unfavorable payer contracts, aging equipment, deferred maintenance, staff turnover, and volume concentrated in one or two surgeons who may leave after the sale. The building looks fine; the risk lives in the contracts and the surgeon panel. Diligence on payer rates, case mix, equipment age, and physician durability is where you find or lose the value.

Do I need surgeon commitments before deciding to build?

Yes. An ASC is a volume business, and a new build with no committed cases is the fastest way to fail. Before design, secure written surgeon intent, understand the specialties and payer mix those cases carry, and check how concentrated the volume is. If a couple of physicians drive most of it, one departure breaks your model. Quantify volume first, then build.

How can Rose help with a build-versus-buy decision?

Rose runs on DataLily's proprietary dataset of 100B plus data points spanning 10M plus providers. Ask Rose to profile the surgeons and case mix in a target market, map the panel and referral patterns tied to an acquisition candidate, benchmark the competitive facility landscape, and surface the payer picture. That grounds your volume and revenue assumptions in operating reality instead of a broker's summary before you commit capital.

Ask Rose

Ask Rose: "I'm deciding whether to build a new ASC or buy an existing one in [market]. Profile the active surgeons and case mix in that market, flag how concentrated the volume is, map referral patterns, and benchmark the competitive facility landscape so I can pressure-test my build-versus-buy assumptions."

Get started

See Rose answer it live

Book 15 minutes and we'll run this question on your own market.